Richard Maroun
General Counsel at Frazier Management LLC
Profile
Rick joined Frazier Healthcare Partners as General Counsel and a Center of Excellence Partner, Legal & Operations in 2014 to help expand and advise the firm’s portfolio of growing healthcare companies.
He brings significant legal, financial, and administrative experience in the generic and biopharmaceutical industry to Frazier’s Growth Buyout team.
Before joining Frazier, Rick was Senior Vice President and General Counsel of Aptalis Pharmaceuticals.
In addition, he has served in numerous senior executive roles for APP Pharmaceuticals, including as Executive Vice President, Chief Administrative Officer, General Counsel, and Business Development Officer.
He also held senior positions with Abraxis BioScience and American BioScience.
Rick has worked with major financial organizations and independent law firms and has held both legal and financial positions with companies including Merrill Lynch, Deloitte & Touche, and McDonough, Holland & Allen.
Rick is also a member of the California State Bar Association, the Los Angeles County Bar Association, and the Association of Corporate Counsel.
Richard Maroun active positions
| Companies | Position | Start |
|---|---|---|
Frazier Management LLC
 Frazier Management LLC Investment ManagersFinance Frazier Management LLC (Frazier Healthcare Partners) is a venture capital subsidiary of Frazier & Co Inc. founded in 1991. The firm is headquartered in Seattle, Washington. | General Counsel | 2013-12-31 |
Former positions of Richard Maroun
| Companies | Position | End |
|---|---|---|
Aptalis Pharma US, Inc.
 Aptalis Pharma US, Inc. Pharmaceuticals: MajorHealth Technology Aptalis Pharma US, Inc. markets pharmaceutical products and services for the treatment of gastrointestinal diseases and disorders. It offers pancrelipase capsules, ursodiol tablets, porfimer sodium for injections, shake mixes, calorie boosters, clearance devices and multivitamin supplements. The firm also provides products for active ulcerative, liver diseases, pancreatic diseases, cystic fibrosis, chronic obstructive pulmonary disease, HIV/AIDS and cancer. The company was founded in 1991 and is headquartered in Wilmington, DE. | General Counsel | 2014-02-27 |
APP Pharmaceuticals, Inc.
 APP Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology APP Pharmaceuticals, Inc. develops, manufactures and markets injectable pharmaceutical products with a primary focus on the oncology, anti-infective, anesthetic/analgesic and critical care markets. It offers one of the most comprehensive product portfolios used in hospitals, long-term care facilities, alternate care sites and clinics within North America and manufactures a comprehensive range of dosage formulations. The company is headquartered in Los Angeles, CA. | General Counsel | 2011-12-30 |
Training of Richard Maroun
| Boston University | Graduate Degree |
| John Carroll University | Graduate Degree |
| The Santa Clara University School of Law | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Frazier Management LLC
Frazier Management LLC Investment ManagersFinance Frazier Management LLC (Frazier Healthcare Partners) is a venture capital subsidiary of Frazier & Co Inc. founded in 1991. The firm is headquartered in Seattle, Washington. | Finance |
APP Pharmaceuticals, Inc.
APP Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology APP Pharmaceuticals, Inc. develops, manufactures and markets injectable pharmaceutical products with a primary focus on the oncology, anti-infective, anesthetic/analgesic and critical care markets. It offers one of the most comprehensive product portfolios used in hospitals, long-term care facilities, alternate care sites and clinics within North America and manufactures a comprehensive range of dosage formulations. The company is headquartered in Los Angeles, CA. | Health Technology |
Aptalis Pharma US, Inc.
Aptalis Pharma US, Inc. Pharmaceuticals: MajorHealth Technology Aptalis Pharma US, Inc. markets pharmaceutical products and services for the treatment of gastrointestinal diseases and disorders. It offers pancrelipase capsules, ursodiol tablets, porfimer sodium for injections, shake mixes, calorie boosters, clearance devices and multivitamin supplements. The firm also provides products for active ulcerative, liver diseases, pancreatic diseases, cystic fibrosis, chronic obstructive pulmonary disease, HIV/AIDS and cancer. The company was founded in 1991 and is headquartered in Wilmington, DE. | Health Technology |
- Stock Market
- Insiders
- Richard Maroun